Lineage Cell Therapeutics Inc (AMEX: LCTX)

Business

Lineage Cell Therapeutics Inc (LCTX): The stock’s intermediate-term indicators point to Buy today

Heidi Phillips

Lineage Cell Therapeutics Inc (LCTX) saw an uptrend of 4.44% in the recent trading with $1.88 being its most recent. ...

Business

What Are Analyst Opinions Regarding Lineage Cell Therapeutics Inc (LCTX)?

Cody Benson

Lineage Cell Therapeutics Inc (LCTX) saw an uptrend of 6.04% in the recent trading with $1.93 being its most recent. ...

Companies

What Are Analysts and Indicators Saying About Lineage Cell Therapeutics Inc (LCTX)

Heidi Phillips

Lineage Cell Therapeutics Inc (LCTX) saw downtrend of -8.16% in the recent trading with $1.8 being its most recent. The ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.